期刊文献+

DREAM对骨癌痛-吗啡耐受大鼠脊髓谷氨酸转运体-1表达的影响

Effect of DREAM on GLT-1 expression in spinal cord in rats with bone cancer pain and morphine tolerance
原文传递
导出
摘要 目的 研究下游调控元件拮抗分子DREAM对骨癌痛-吗啡耐受大鼠脊髓谷氨酸转运体-1(GLT-1)表达的影响.方法 健康雌性SD大鼠60只,体质量200 ~ 230 g,按随机数字表法分为癌痛组(CP组,n=48)和假手术组(S组,n=12).于接种前1 d(T0),接种后第7天(T1)、14天(T2)、18天(T3)、19天(T4)、21天(T5)、25天(T6)和28天(T7)检测机械痛阈.术后T2~ T3,随机取CP组中36只大鼠行皮下吗啡注射,每日单次剂量依次为10、20、30、40和60 mg/kg,3次/d.T4时,皮下注射吗啡3 mg/kg.术后20 ~ 25 d,依鞘内注射物质不同,将经吗啡处理过的大鼠分为吗啡耐受组(MT组,n=12)、RNAi组(R组,n=12)和载体组(V组,n=12).术后28 d,取其L4脊髓,检测术侧脊髓DREAM和谷氨酸转运体-1(GLT-1)的表达变化.结果 (1)机械痛阈:与S组比较,CP组、MT组、V组和R组在T1、T3、T5~T7时降低,CP组在T2时降低,MT组、V组和R组在T4时降低;与CP组比较,MT组、V组及R组在T2 ~T3时升高(P<0.01),T4时降低(P<0.01),R组在T5时降低(P<0.01),MT组和V组在T5~T7时降低(P<0.01).与MT组和V组比较,R组在T6~T7时升高(P<0.01).(2)脊髓DREAM基因mRNA和DREAM蛋白含量:与S组比较,其他各组脊髓DREAM基因mRNA和DREAM蛋白含量均显著增高(P<0.01);与CP组比较,MT组和V组表达均增加(P<0.01),R组表达减少(P<0.01);与MT组和V组比较,R组表达减少(P<0.01).(3)GLT-1表达:与S组比较,其他各组GLT-1表达均减少(P<0.01);与CP组比较,MV组、V组和R组表达G LT-1表达均减少(P<0.01).结论 DREAM参与骨癌痛-吗啡耐受机械痛敏的维持,对脊髓GLT-1的表达未见明显影响. Objective To investigate the effects of downstream regulatory element antagonist modulator (DREAM) on the expression of glutamate transporter-1 (GLT-1) in spinal cord in rats with bone cancer pain and morphine tolerance.Methods Sixty female healthy Sprague-Dawley (SD) rats weighing 200 ~230 g were randomly divided into tow groups,group Ⅰ cancer pain (CP,n =48) and group Ⅱ Sham (S,n =12).Cancer pain in each group was produced by inoculation of syngenetic Walker 256 rat mammary gland carcinoma cells (5 × 105) to left tibia.Pain threshold to mechanical stimulus was measured before (baseline) and after the surgical procedure.From 14 d to 18 d after the inoculation of carcinoma cells,36 rats from group CP received subcutaneous injection of morphine at 3 times per day with doses increasingly from 10 mg/kg initially to 20 mg/kg,30 mg/kg,40 mg/kg,and 60 mg/kg.Equal volume of normal saline was applied to the 12 rats left in group CP.On 19th day after the carcinoma cells inoculation once subcutaneous injection of morphine at 3mg/kg was performed in all rats in group CP.From the next day,the rats in group CP ever receiving injections of morphine for 5 days were randomized into thre subgroups,including subgroups morphine tolerance (MT,n =12),vehicle (V,n =12),and RNAi (R,n =12).They were injected intrathecally with 20 μl of normal saline (NS),10 μl vehicle plus 10 μ1 NS,and 10 μ1 of DREAM-shRNA plus l0 μ1 NS,respectively,once a day for 5 days.Focusing on the affected limb,mechanical pain threshold was measured one day before surgery (T0),and at day7 (T1),day 14 (T2),day 18 (T3),day 19 (T4),day21 d (T5),day 25 (T6),and day 28 (T7) after surgery.The animals were sacrificed at day 28 after the procedure.The lumbar 4 segments in rats were removed for detection of DREAM and GLT-1.Results The mechanical threshold was significantly decreased at T1 compared to the baseline in all groups,returned to the baseline at T2 ~ T7 in group S,at T4 in group CP,and at T2 in group MT,V,and R,but remained low at T5 ~T7 in group CP,and at T3 ~T7 in group MT,V,and R.Compared to that at T1,it was decreased at T2 ~T3 and T5 ~ T7 in group CP,at T4 ~ T7 in group MT and V,and at T4 ~ T5 in group R,going back to the baseline at T4 in group CP and at T2 in group MT,V and R,and increased at T6 ~ T7 in group R.Compared to that in group S,the mechanical threshold in group CP,MT,V and R was decreased,and lower at T2 in group CP and at T4 in group MT,V and R.Compared to that in group CP,the mechanical threshold was significantly higher at T2 ~ T3 but lower at T4 in group MT,V,and R,decreased at T5 in group R and at T5 ~ T7 in group MT and V.The mechanical threshold was increased at T6 ~ T7 in group R and higher than that in groups MT and V.The expression of DREAM,compared to that in group S,was down-regulated in other groups.Compared to group CP,increment was shown in groups MT and V,and decrease was exhibited in group R.It was cut down in group R compared to that in groups MT and V.Compared to group S,GLT-1 was decreased in other groups.It was down-regulated in groups MT,V and R compared to group CP.Conclusions DREAM is involved in the development of allodynia after morphine tolerance in rats with bone cancer pain.No evidence in this study supports a link between DREAM and GLT-l in spinal cord.
出处 《中国医师杂志》 CAS 2014年第12期1593-1597,共5页 Journal of Chinese Physician
基金 浙江省自然科学基金(Y2091107)
关键词 基因表达调控 肿瘤 骨肿瘤/并发症 疼痛/病因学 吗啡/药理学 药物耐受性 谷氨酸/代谢 Gene expression regulation, neoplastic Bone neoplasms/complications Pain/etiology Morphine/pharmacology Drug tolerance Glutamic acid/metabolism
  • 相关文献

参考文献35

  • 1Lipttm A. Bisphosphonatcs and breast carcinoma[ J ]. Cancer, 1997, 80(8 Suppl) : 1668-1673.
  • 2Fulfaro F, Casuccio A, Ticozzi C, et al. The tale of bisphospho- nates in the treatment of painful metastatic bone disease: a review of phase 111 trials[.[]. Pain, 1998, 78(3) : 157-169.
  • 3Payne R. Practice guidelines fi~r cancer pain therapy. Issues perti- nent to the revision of national guidelines[J]. Oncology( Williston Park), 1998, 12(11 A): 169-175.
  • 4Payne R. Mechanisms and management of bone pain[ J ]. Cancer, 1997, 80(8 Suppl) : 1608- 1613.
  • 5Chcng HY, Pitcher GM, 1..aviolette SR, et al. DREAM is a criti- cal transcriptional repressor for pain modulation [ J]. Cell, 2002, 108(1): 31-43.
  • 6Sung B, Lira G, Mao J. Altered expression and uptake activity ofspinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats [ J ]. J Neurosci, 2003,23 (7) :2899-2910.
  • 7Mao J, Sung B, Ji RR, et al. Chronic morphine induces downreg- ulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity[ J]. J Neurosci, 2002, 22 (18) :8312-8323.
  • 8Yaksh TL, Rudy TA. Chronic catheterization of the spinal sub- araehnoid space[J]. Physiol Behav, 1976, 17(6) : 1031-1036.
  • 9姚明,杨建平,王丽娜,成浩,张艳兵,许期年,吴翼伟.腹水传代与体外培养Walker 256癌细胞系建立大鼠骨癌痛模型的可行性[J].中华医学杂志,2008,88(13):880-884. 被引量:61
  • 10Medhurst SJ, Walker K, Bowes M, .et al. A rat model of bone cancer pain[J]. Pain, 2002, 96(1-2) : 129-140.

二级参考文献44

  • 1Rubens RD. Bone metastases-the clinical problem. Eur J Cancer, 1998, 34: 211-213.
  • 2Medhursta SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain, Pain, 2002, 96:129-140.
  • 3Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 2005, 118 : 125-136.
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci ,1999, 19: 10886-10897.
  • 5Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res, 2005, 65 : 9426-9435.
  • 6Walker K. Fox AJ, Urban LA. Animal models for pain research. Mol Med Today, 1999, 5: 319-321.
  • 7Corbello Pereira SR, Darronqui E, Constantin J, et al. The urea cycle and related pathways in the liver of Walker-256 tumorbearing rats. Biochim Biophys Acta, 2004, 1688: 187-196.
  • 8Yao YM, Liu QG, Yang W, et al. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2003, 2: 242-246.
  • 9Chew EC, Wallace AC. Demonstration of fibrin in early stages of experimental metastases. Cancer Res, 1976, 36:1904-1909.
  • 10Menendez L, Lastra A, Fresno MF et al. Initial thermal heat hypoalgesia and delayed hyperalgesia in a routine model of bone cancer pain. Brain Res, 2003, 969: 102-109.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部